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Synopsis 
 
 
In the post genomic era with the massive production of biological data the understanding of factors 
affecting protein stability is one of the most important and challenging tasks for highlighting the 
role of mutations in relation to human maladies. The problem is at the basis of what is referred to as 
molecular medicine with the underlying idea that pathologies can be detailed at a molecular level. 
To this purpose scientific efforts focus on characterising mutations that hamper protein functions 
and by these affect biological processes at the basis of cell physiology. New techniques have been 
developed with the aim of detailing single nucleotide polymorphisms (SNPs) at large in all the 
human chromosomes and by this information in specific databases are exponentially increasing.  
Eventually mutations that can be found at the DNA level, when occurring in transcribed regions 
may then lead to mutated proteins and this can be a serious medical problem, largely affecting the 
phenotype. Bioinformatics tools are urgently needed to cope with the flood of genomic data stored 
in database and in order to analyse the role of SNPs at the protein level. In principle several 
experimental and theoretical observations are suggesting that protein stability in the solvent-protein 
space is responsible of the correct protein functioning. Then mutations that are found disease related 
during DNA analysis are often assumed to perturb protein stability as well. However so far no 
extensive analysis at the proteome level has investigated whether this is the case. Also 
computationally methods have been developed to infer whether a mutation is disease related and 
independently whether it affects protein stability. Therefore whether the perturbation of protein 
stability is related to what it is routinely referred to as a disease is still a big question mark.  In this 
work we have tried for the first time to explore the relation among mutations at the protein level and 
their relevance to diseases with a large-scale computational study of the data from different 
databases. To this aim in the first part of the thesis for each mutation type we have derived two 
probabilistic indices (for 141 out of 150 possible SNPs): the perturbing index (Pp), which indicates 
the probability that a given mutation effects protein stability considering all the “in vitro” 
thermodynamic data available and the disease index (Pd), which indicates the probability of a 
mutation to be disease related, given all the mutations that have been clinically associated so far. 
We find with a robust statistics that the two indexes correlate with the exception of all the mutations 
that are somatic cancer related. By this each mutation of the 150 can be coded by two values that 
allow a direct comparison with data base information. Furthermore we also implement 
computational methods that starting from the protein structure is suited to predict the effect of a 
mutation on protein stability and find that overpasses a set of other predictors performing the same 
task. The predictor is based on support vector machines and takes as input protein tertiary 
structures. We show that the predicted data well correlate with the data from the databases.  All our 
efforts therefore add to the SNP annotation process and more importantly found the relationship 
among protein stability perturbation and the human variome leading to the diseasome.  
 
Key words:  perturbing index, disease index, disease class index, disease related mutations, 
correlation coefficients, protein function, SNP annotation. 
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Chapter1. Introduction 
 
In the post-genomic era a great shift of interest is occurring in computational studies aiming at 
deciphering the complexity of our genetic code. Methods derived from computer science help in 
developing tools that are extremely useful in analysing genomes and proteomes and modelling all 
the complexities of the area on the basis of all the molecular interactions that supports life in the 
cells. DNA in each cell encodes for proteins that are considered to be the gear of living tissues in 
which they carry out all the chemical reactions necessary for life. Proteins are endowed with three-
dimensional structures that are relevant for their functions. When mutations occur at the DNA level, 
proteins may also be affected to the point that their stability is perturbed. A crucial problem is to 
understand to which extent this mechanism is responsible for maladies. In this work we are 
therefore trying to look inside the protein world in the context of small variations in their sequences. 
A brief introduction on protein structure is therefore at hand.  
  
1.1 The protein universe 
 
Proteins are polymers of 20 different amino acid molecules, linked covalently by peptide bonds, 
generating long backbones where the protein identity consists in the specific position along the 
sequence of the residue side chains. A protein is therefore the sequence of its residues with a 
variable length spanning from 40 up to thousands of residues in the over 10 millions of proteins 
from over 1000 species that are presently known in the data bases.  
 
 
 
Figure1.1 A typical covalent bond formed between two amino acids. R1 and R2 are the different 
side chains of each amino acid.  
 
One end of every polypeptide, called amino terminal or N-terminal, has a free amino group. The 
other end, with its free carboxyl group, is called the carboxyl terminal or C-terminal. A typical 
protein contains 200-300 amino acids but some proteins like peptides are smaller and yet other 
proteins like titans (about 30,000 residues) are much larger than the average protein size. Function 
is therefore depending on the specific protein sequence that in turn and in the cell space is organised 
in a three-dimensional structure. Routinely more proteins can take part into what is called a 
biological process and several thousands of biological processes are the basis of what is routinely 
referred to as a cell life. 
 
1.2 Amino acids 
 
Twenty amino acids are found in proteins (Figure 1.2). The amino acids differ from each other at 
the level of the portion of molecule called side chain [‘R’ in Figure 1.1]. Different residues in the 
protein chain are responsible of the specific structure, function and physicochemical properties of 
the different proteins.  
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. 
Figure 1.2. 20 common amino acid residues grouped according to the physico-chemical 
properties like Polar acidic, Polar basic, Nonpolar hydrophobic and polar uncharged. Each Box 
shows the name of the amino acid (AA), the  three-letter code of AA, the 1- letter code of AA and its 
Molecular weight of the amino acid along with the corresponding structure. 
 
1.3 The protein structure 
 
There are four main levels of protein structure (Figure 1.3).  
 
(1) Primary Structure. The primary structure of proteins refers to the linear chain and order of 
amino acid residues present in the proteins. The sequence of amino acid residues in a 
polypeptide is dictated by the codons in the messenger (mRNA) molecules.  
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(2) Secondary Structure. A local organisation of the protein backbone stabilised by hydrogen 
bonding that is basically classified into α helix and β strand, depending on the geometrical 
parameters. 
 
(3) Tertiary Structure. The tertiary structure refers to the complete three-dimensional (3D) 
structure of the protein chain. The α helices and β sheets get folded into a compact globule. 
Folding of secondary structure into tertiary structure is driven by many interactions like 
hydrogen bonding, hydrophobic forces, electrostatic forces and Van der Waals forces. 
 
(4) Quaternary Structure. Many proteins contain two or more different polypeptide chains, 
which are held together by the association of same non-covalent forces that helped in 
stabilization of tertiary structure. The quaternary structure of the protein is formed by the 
monomer-monomer interaction of the proteins. The proteins with multiple polypeptide 
chains are called oligomeric proteins. The quaternary proteins with identical subunits are 
termed as homo-oligomers, whereas proteins containing many different polypeptides are 
termed as hetero-oligomers.  
 
 
 
Figure 1.3 The protein from its primary to its quaternary structure. 
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1.3.1 The relation of structure and function 
 
The protein structure specifies its function. Large portion of the structure that generally referred to 
as protein domains are basically related to given protein functions, and interestingly due to 
evolutions even distantly related proteins may have in common similar domains when they perform 
the same functions in different species. Summing up, function is generally conserved when the 
structure is conserved, even when the sequence varies. 
 
1.4 Mutations 
 
Mutations are changes in the nucleotide sequence of the genetic material. Mutation is an error, 
which can occur any time while copying the genetic material during cell division, or by some 
external means like exposure to UV radiations or ionising radiations or by exposure to some 
chemicals or viruses. Any physical or chemical agent that causes mutation is termed as Mutagens. 
A mutation in any residue of a protein may affect the structure and therefore the functionality of the 
protein, which may further affect the metabolism of the organism and may lead to some disease.   
 
1.4.1 Single Nucleotide Polymorphism (SNP) 
 
A Single Nucleotide Polymorphism (SNP) is a single base mutation in DNA, the most simple form 
and most common source of genetic polymorphism in the human genome (90% of the human 
genome polymorphisms). Two types of nucleotide base substitutions give rise to SNPs: 
 
 A transition substitution between purines (A, G) or between pyrimidines (C, T). This type 
of substitution constitutes two thirds of all SNPs. 
 
 A transversion substitution that occurs between a purine and a pyrimidine.  
 
1.4.2 Sequence Variation 
 
Sequence variation caused by SNPs can be measured in terms of nucleotide diversity, the ratio of 
the number of base differences between two genomes over the number of bases compared. This is 
approximately 1/1000 base pairs between two equivalent chromosomes [Jin Li et al (1999)]. SNPs 
are not uniformly distributed over the entire human genome, neither over all chromosomes and 
neither within a single chromosome. There are one third of SNPs found within the coding regions to 
non-coding region SNPs. It has also been shown that sequence variation is much lower for the sex 
chromosomes. Within a single chromosome, SNPs can be concentrated for a specific region, usually 
implying a region of medical or research interest.  
 
1.4.3 SNPs in coding regions 
 
A SNP in a coding region may have two different effects on the resulting protein:  
 
 Synonymous SNP: when the substitution causes no amino acid change to the protein it 
produces. This is also called a silent mutation.  
 
 Non-Synonymous (nsSNP): when the substitution results in an alteration of the encoded 
amino acid. A missense mutation changes the protein by causing a change in codon. A 
nonsense mutation results in a misplaced termination codon. One half of all coding sequence 
SNPs result into non-synonymous codon changes.  
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1.5 The thermodynamics of the folding and unfolding of proteins 
 
The primary structure of a protein is a linear polypeptide chain. After synthesis on a ribosome, the 
polypeptide chain quickly transforms from an unstructured, random conformation (the unfolded 
state) to its unique native conformation (folded) state, in which the protein carries out its function. 
Despite of this relatively easy concept of protein folding, defining the folding pathway from a 
protein’s primary structure to its tertiary structure has proven to be an immensely challenging task 
to solve [Fitzkee et al. (2005); Kang and Kini (2009)]. However, much is known about the forces 
that distinguish unfolded and folded forms. The thermodynamic stability of a protein is defined by 
the free-energy difference between the unfolded state and the folded state [Pace 1990] as follows: 
 
ΔΔG = ΔGunfold - ΔGfold                                                 1.1 
 
The energetic difference between the folded and unfolded states is due to differences in the balance 
of intramolecular interactions, interactions with the surrounding medium, and entropic factors. The 
folded state is more stable (with lower ΔG) than the unfolded state (with greater ΔG). Many studies 
have confirmed that a high proportion of globular proteins are marginally stable under physiological 
conditions since the free energy of folded conformations are generally only 5 to 10 kcal/mol higher 
than for unfolded [Privalov and Khechinashvili (1974); Pace (1975); Ruvinov et al. (1997); Vogl et 
al. (1997); Giver et al. (1998)]. Experimental and theoretical work has provided mechanistic details 
of the forces that govern the folding and unfolding of proteins. These forces include hydrogen 
bonding interactions [Mirsky and Pauling 1936], electrostatic interactions [Thornton (1981); Cho 
and Raleigh (2006)], Van der Waals interactions [Chen and Stites (2001)], and hydrophobic 
interactions [Dill (1990)].  
 
The major destabilizing force among all is the conformational entropy [Pace et al. (1996)]. These 
various interactions that arises from the functional side chains of amino acids, contribute with 
various strengths to the protein stability and protein folding process [Dill (1990); Yang et al. 
(2007); Dill et al. (2008)]. The final structure of the protein monomer or complex is a result of an 
understated balance between stability posing and stability opposing forces and thus a single 
mutation may shift this balance and can significantly perturb the whole protein structure and thus its 
function [Matthews (1987); Alber (1989)]. Intramolecular interactions define the overall structure 
and stability of a protein, as well as regions that can undergo conformational rearrangements. Also 
functional properties, such as catalysis, allosteric regulation and ligand binding, arise from the same 
interactions that define stability. Although much is known about individual forces, understanding 
the precise interplay of intermolecular interactions is still a problem [Mounce et al. (2009)]. 
 
1.6 Biomedical relevance of SNPs 
   
One of the fundamental problems in protein research is the understanding of protein stabilization by 
complex physical interactions. This problem has attracted the attention also in molecular medicine 
since when it has been noticed that some diseases such as amyloidisis are likely to be related to 
changes in protein stability due to mutations occurring in the protein sequence [Pepys et al (1993)]. 
The protein stability mechanism has been studied by using site-directed mutagenesis followed by 
thermodynamic measurements and structure determination [Matthews et al (1993)]. In the 
biomedical context SNPs are very important, as they are the most common source of variation in 
the human genome. Due to the redundant nature of the RNA triplet code that encodes proteins, 
many of these SNPs may not cause an amino acid change in the encoded protein (synonymous 
mutations). However, when a SNP causes an amino acid change (a non-synonymous mutation) 
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there may be an effect on the structure and function of the encoded protein. Loosing of function 
may lead to disease. It would therefore be extremely useful to be able to predict which mutations 
are likely to cause disease. Identifying those SNPs that promote susceptibility or protection to 
complex diseases will aid early diagnosis, prevention and help in finding treatments.  
 
 
 
 
A SNP may affect the function of a protein mainly in three ways [Worth et al (2007)].  
 
 Firstly, a SNP may affect the functional residues of a protein i. e. the active site or protein-
protein interaction site, impairing the protein's ability to carry out its normal function and 
hence affecting the molecular pathway within which the protein functions. 
 
 Secondly, destabilizing the protein fold (increasing the ratio of unfolded protein to folded 
protein) or stabilizing it (decreasing the ratio of unfolded protein to folded protein).  
 
 Thirdly by causing protein aggregation. 
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Chapter 2. The state of the art: reviewing literature 
 
2.1 In-sights 
 
The question of how changes protein stability after a single point mutation has been a matter of 
investigation for scientists for a long time. Starting the sixties, several theoretical and computational 
methods have been developed to compute stability change promoted by residue mutations in the 
protein fold. The earliest approaches involved free energy calculations with detailed models 
coupled to semi-empirical potentials [Basch et al, 1987; Tidor and Karplus, 1991]. Broadly there 
are two distinct in-silico approaches to predict the stability of proteins after point mutations, energy 
function and machine learning based methods. 
 
2.1.1 Energy function-based approaches 
 
Methods that utilize energy functions can be further subdivided into two types: physical based and 
knowledge based. The first ones based on physical pair wise interaction potentials directly allow the 
calculations of ΔΔG values upon substitutions by adopting classical force fields [Alexander 
Benedix et al., 2009; Masso and Vaisman, 2008; Parthiban et al, 2006; Yin et al, 2007; Pokala et al., 
2005; Rohl et al, 2004; Gao et al, 1989; Bash et al, 1987]. This approach, while very useful for 
small protein sets, is however computationally expensive and cannot be applied on large-scale 
investigation [Capriotti et al, 2006]. Other methods have been recently developed and they are 
briefly described in the following sections. 
 
2.1.1.1 PoPMuSiC vol 1.0 
 
The first version of PoPMuSiC is a knowledge-based predictor [Gilis and Rooman, 2000] designed 
to predict protein stability upon single point mutation. It basically uses the backbone dihedral 
potentials derived from the protein structures. Proline mutation is not allowed since it is suspected 
to modify the backbone structure. The threshold value for non-local interactions is above 15 
residues. 141 protein structures are used to extract the torsion angle potentials and distances 
between the amino acid residue atoms. The method takes as input the protein structure and its 
schematic representation is shown in Figure 2.1. Potentials are derived from observed frequencies 
of sequence and structure patterns in a dataset of 141 high-resolution protein X-ray structures with 
< 25% sequence identity or no structural similarity. Two types of potentials, called torsion 
potentials, consider only local interactions along with the sequence and Cµ-Cµ potentials. These are 
distance potentials dominated by non-local, hydrophobic interactions, purely based on the 
propensities of pair amino acid residues (am, aj) at positions m and j along the sequence at a fixed 3-
D distance, dmj, between the side chain centroids Cµ. PoPMuSiC computed values well correlate 
with the measured folding free energy changes since the Pearson correlation coefficient is 0.80. 
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Figure 2.1 The flow chart of PoPMuSiC 1.0 [Gilis and Rooman, 2000] 
Input 
PDB file of protein 
+ 
Position 
+ 
One letter residue code to be 
mutated 
Effective 
potential 
calculation 
Mutated to all the 19 
possibilities Possible mutation 19 
Possible 
mutation 19 
Calculation of ΔΔG 
Database – 
derived 
potentials 
Most stabilizing 
mutation 
Neutral Mutation Most destabilizing 
mutation 
Output 
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2.1.1.2 Fold-X  
 
Fold-x [Guerois et al, 2002] uses an empirical force field and computes the energetic effect of point 
mutations as well as the interaction energy of protein complexes (including Protein-DNA). FoldX 
mutates protein and DNA side chains using a probability-based rotamer library, while exploring 
alternative conformations of the surrounding side chain. It can be used for a number of purposes, 
including prediction of the effect of point mutations or human SNPs on protein stability or protein 
complexes, protein design to improve stability or modify affinity or specificity and homology 
modelling. The energy function of FoldX includes terms, which are found to be important for 
protein stability, where the energy of unfolding (ΔG) of a target protein is calculated as  
 
∆G = ∆Gvdw + ∆GsolvH + ∆GsolvP + ∆Ghbond + ∆Gwb + ∆Gel + ∆Smc + ∆Ssc    2.1 
 
 
∆Gvdw  = Sum of Van der Waals contributions of all atoms 
∆GsolvH = Difference in solvation energy for apolar groups of residues in folded and                    
unfolded states 
∆GsolvP = Difference in solvation energy for polar groups of residues in folded and unfolded states 
∆Ghbond= Extra stabilizing free energy by water bridges 
∆Gel = Electrostatic contribution of charged groups 
∆Smc = Entropy cost for fixing backbone in the folded state 
∆Ssc = Entropy cost for fixing a side chain in a particular conformation. 
 
The program is freely available (http://fold-x.embl-heidelberg.de ) and it was trained on a dataset  of 
339 mutations in 9 proteins. Testing was done on a dataset of 667 mutations in 82 proteins. The 
method reaches a Pearson correlation of 0.83 with a standard deviation of 0.81 kcal/mol.  
 
2.1.2 Machine Learning methods 
 
In Computational Biology, machine-learning methods are often adopted in order to perform a 
classification of data described with complex features. They are supervised methods since they are 
able to extract the relevant information from a set of data (the training set) for which the correct 
classification in known. Machine learning methods include Neural Networks (NNs), Support Vector 
Machines (SVMs), Hidden Markov Models (HMMs). Each one of these tools is endowed with a set 
of trainable parameters, whose values are determined by means of training algorithms that are 
suited to minimise the error rate of the classification of the data included in the training set. 
Machine learning methods are able to generalise the information extracted from the training set to 
new data with unknown classification and can be therefore used as predictors. Statistical scoring 
indexes such overall accuracy and Matthew’s correlation coefficient have to be evaluated on testing 
sets that contains data completely unrelated to those included in the training set. The size and 
quality of training set is crucial in determining the performances of a prediction method. Owing to 
their generality, most of machine learning tools can extract information starting from different types 
of input. In the field of the prediction of the effect of protein mutations on protein stability, different 
tools have been developed. They analyse information derived from either the protein structure or 
sequence. Structure-based predictors are usually more efficient, while sequence-based methods 
have a larger applicability, since the do not require the protein to be endowed with a known 3-D 
structure. Here we will briefly review only methods that have been developed at the Biocomputing 
Group since they are among the state of the art predictors and later on we will focus in improving 
over their scores. 
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2.1.2.1 Multi Layer Neural Networks 
 
Artificial neural networks are connectionist models, in which the computation is performed by 
many elementary units, called neurons. They can be activated or not, depending on the signals that 
they receive from other neurons (including the input units). The connection between two neurons 
(synapse) is unidirectional and it is modulated by a numerical synaptic weight. Figure 2.2 shows the 
McCullogh-Pitts (MCP) model of an artificial neuron. The neuron receives weighted signals from 
other neurons (of from the input) and integrates them. If the addition of weighted inputs exceeds a 
threshold value, typical of each neuron, the neuron is activated. The value of the activation is: 
 
νk= X1Wk1+X2Wk2 +…+XiWki  - Tk                                                 2.3 
 
Where  X = Signal from of the neurons (or from input) 
W= Weight  
  T= Threshold  
  
The trainable parameters of a NN are the synaptic weights between neurons and the threshold value 
of each neuron. 
 
 
Figure 2.2 The MCP neuron model 
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Usually, the output of the neuron, denoted as yk, is modulated by an activation function denoted 
with φ 
 
(1) Step Function. The value of step function is 0 if the activation is lower than 0 that is if the sum 
of inputs is lower than the threshold value of the neuron (Tk) and 1 otherwise: 
 
                                                                         2.5 
(2) Piecewise Linear Function. The function is continue and linear in different sub domains 
 
                                                                                       2.6 
 
(3) Sigmoid Function: This function may take the range between 0 and 1 as in the case of the 
logistic function, or between –1 and 1, as in the case of hyperbolic tangent. 
The equation of the hyperbolic tangent is: 
 
                                                                        2.7 
 
 
The NN topology is defined by the pattern of the synaptic connections between neurons. In a feed 
forward NN neurons are organized in layers connected in unidirectional way. The flux of 
information proceeds from the input layer towards the output layer. A steepest descent based 
algorithm that aims at minimizing the error rate on the training data is used for training the 
parameters of a feed forward NN. The algorithm is known as “backpropagation” (Rumelhart et al, 
1986).  
 
 
2.1.2.2 Support Vector Machines 
 
Support Vector Machines (SVM) are a supervised method that perform a binary linear classification 
by searching for a separating hyperplane that maximises the margin, that is the distance between the 
hyperplane itself and the nearest data in each class.  The Figure 2.3 shows a simple example of 
hyperplanes that correctly classify the different circles. The line in plane (a) performs a better 
classification than that on plane (b) because the separation margin is much larger. The margin is 
determined only by a subset of the data, called support vectors. SVMs can also solve non-linearly 
separable problems by introducing kernel techniques that represent, in an implicit way, the mapping 
of the original data into a feature space in which linear separation is easier. The most adopted 
kernels are the polynomial and the radial basis function (RBF) kernels. Predictive performance of 
SVM-based methods represents the state-of-the art in many real world applications [Cristianini and 
Shawe-Taylor, 2007].  
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Figure 2.3 A scheme of the discriminating capability of Support Vector Machines (SVMs). 
 
2.1.2.3 IMutant 2.0  
 
Capriotti et al (2005) adopted SVMs to exploit information from protein structures. Previous 
implementations by the same group, based on neural network were able to compute only the sign of 
the free energy change (minus or plus) after a single point mutation. In the SVM implementation 42 
and 43 input vectors code for sequence and structure, respectively. By this the first two vectors code 
for pH and temperature at which the stability energy change of the protein after the mutation was 
experimentally determined (data are available in the ProTherm data base, 
(http://gibk26.bse.kyutech.ac.jp/jouhou/Protherm/protherm.html). The next 20 values represent the 
mutated residue (–1 and 1 for the residue to be deleted and substituted residues respectively and 0 
for the remaining other residues). The other 20 values encode the residues, which are in contact 
with the target (mutated) residue in the sphere of 0.9 nm centered on the coordinates of the residue 
that undergoes mutation in the case of structure-based prediction. In the case of sequence-based 
prediction these 20 values comprise the types of residues present in a window of length 19 
stretching from N-terminus to C-terminus.  For a structure based prediction RSA value (Relative 
Solvent Accessible Area) calculated with the help of DSSP program is also included as the 43rd 
vector. I Mutant 2.0 was trained on dataset retrieved from ProTherm (December, 2004). It was 
trained/tested with a cross-validation procedure. It reaches accuracy of 80% and a Person 
correlation value of 0.71 (with a standard error of 1.30 kcal/mol) when experimental ΔΔGs are 
correlated to the predicted ones starting from the protein structure. When prediction is sequenced 
based accuracy drops to 77% and Pearson correlation is 0.62 (with a standard error of 1.45 Kcal per 
mole).  [Capriotti, et al, 2005]. The output includes a table of 19 rows* 6 columns (19 residues that 
are different from the one present in the sequence at a selected position), value and sign of ΔΔG 
prediction (Increase/decrease), original and mutated one letter code of residue, solvent accessible 
surface area, reliability index (RI) temperature and pH at which the prediction was carried out is 
obtained. By definition ΔΔG values for stabilizing mutation is greater than zero and for 
destabilizing mutation is less than zero [Capriotti et al, 2006)]. 
    
2.1.2.4 I-Mutant3.0  
 
I Mutant 3.0 [Capriotti, et al, 2008] discriminate three classes: stabilizing, destabilizing and neutral 
single point mutations. It can be based on sequence and it reaches accuracy of 56% and average 
Matthew’s correlation coefficient of 0.27. It can also considers structures and then the overall 
accuracy is 61% with an average Matthew’s mean correlation coefficient of 0.35.   
 
(a) Larger margin (b) Smaller margin 
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2.1.2.5 PHD-SNP  
 
Considering a protein sequence the mutation can or cannot be disease-related. Considering a data 
based of annotated SNPs, routinely associated to monogenetic diseases. Capriotti et al [2006] 
developed a method based on decision tree with a SVM-based classifier (SVM-Sequence) coupled 
to a SVM-Profile trained on sequence profile information. Scoring was as high as 74% accuracy 
with Matthew’s correlation coefficient equal to 0.46. 
 
Table 2.1 gives a brief description about the information about the literature-based performance of 
different predictors at a glance.  
 
Table 2.1 Literature based performance of different predictors 
 
Predictors Accuracy 
 
Correlation 
 Coefficient 
 
Method Reference 
PoPMuSiC 
v1.0 
- 0.80 (Pearson correlation 
coefficient) 
Knowledge based 
potential  
Gilis and 
Rooman, (2000) 
Fold-x 61% 0.83 (Pearson correlation 
coefficient)  
Knowledge based 
potential 
Guerois et al, 
(2002) 
I Mutant 2.0 
 
77% (sequence 
based 
prediction) 
80% (structure 
based 
prediction) 
0.62 (sequence based 
prediction -Pearson 
correlation coefficient) 
0.71 (structure based 
prediction- Pearson 
correlation coefficient)  
Machine learning 
method 
(Support Vector 
Machine) 
Capriotti, et al, 
(2005) 
I Mutant 3.0 56% (sequence 
based 
prediction) 
61% (structure 
based 
prediction) 
0.27 (sequence based 
prediction- average MCC) 
0.37 (structure based 
prediction- average MCC) 
Machine learning 
method 
(Support Vector 
Machine) 
Capriotti, et al, 
(2008) 
PHD-SNP 74% 0.46 (Matthew’s 
correlation coefficient)  
Machine learning 
method 
(Support Vector 
Machine) 
Capriotti et al, 
(2006) 
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Chapter 3. Materials and Methods  
 
3.1 Datasets 
The data used in this work can broadly be classified as thermodynamic data and SNPs related data. 
The thermodynamic data refers to the online data with prior calculated thermodynamic properties of 
proteins like Gibbs free energy change (ΔΔG). The key aspect of the research in genetics is 
associating sequence variations with heritable phenotypes. As explained earlier the most common 
types of variations are SNPs, which occur approximately once every 100 to 300 bases. As these 
SNPs are expected to facilitate large-scale genetic studies, there has recently been a great interest in 
SNP discovery and detection and databases related to it. SNP related data includes the accurate 
information regarding the residue substitution and diseases related to it. 
  
3.1.1 Thermodynamic data  
 
The thermodynamic data for this study was derived from ProTherm, released on 31 March 2010. It 
contains 4044 mutations in 212 proteins collected from 10341 experiments [Kumar et al., 2006]. 
After excluding two membrane proteins we downloaded the data of 3089 experiments, which 
correspond to 141 SNPs in 129 proteins. The dataset comprises 55% data from eukaryotes, and rest 
45% data from prokaryotes. The dataset contains entries from different organisms including 26% 
data from Homo sapiens.  
 
The majority of ΔΔG values (63% values) lie in the range of 1 kcal/mol (Figure 3.1). The average 
ΔΔG value in the dataset was calculated to be –0.79 kcal/mol. We classified the mutation as non-
perturbing if the associated | ΔΔG | value is less than or equal to 1 kcal/mol and perturbing 
otherwise. Therefore 
 
If  |ΔΔG|   1 kcal/mol  mutation non-perturbing protein stability  
    
    |ΔΔG|  > 1 kcal/mol  mutation perturbing protein stability 
 
In case that multiple experiments for the same mutation in the same protein are present with 
different ΔΔG values the following rules were followed: 
 
(1) The majority rule was applied to decide if the mutation is non-perturbing or perturbing 
 
(2) If the number of perturbing experiments is the same of the non-perturbing ones the average 
ΔΔG value was considered 
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Figure 3.1 Distribution of G values corresponding to 141 SNP types found in ProTherm. Each 
bar represents the fraction of experiments (total is 3089, Table 3.1) with G values in the 
corresponding range. Mutations corresponding to G < -1 Kcal/mol and G>1 Kcal/mol are 
labeled as perturbing the protein stability (see text for details). ProTherm is at 
http://gibk26.bse.kyutech.ac.jp/jouhou/Protherm/protherm.html. 
 
3.1.2 SNP data 
 
The SNP and disease related data were derived from two databases: UniProt KB and COSMIC 
(Table 3.1). The UniProt KB (Universal Protein Resource) release is 2010_04/23 March 2010 
(http://www.uniprot.org/docs/humsavar) [Yip et al, 2008]. The entries without any disease 
annotations, annotated as polymorphism, were considered to be neutral mutations. We downloaded 
35,557 mutation examples in 7,892 proteins. Out of them 13,456 were disease related mutations and 
22,101 were neutral mutations. 
  
Another set of SNPs, related to somatic cancer, was downloaded from COSMIC 
(www.sanger.ac.uk/genetics/CGP/cosmic/), release v46, 8 March 2010 [Forbes et al., 2010]. We 
extracted 5,063 mutation examples in 2111 proteins, 5, 061 mutation examples were disease related 
and only 2 mutations were neutral. There were 2,110 proteins containing only disease related 
mutations and a single protein with both disease related and neutral mutations. 
 
Comparing COSMIC dataset with Uniprot KB we found 3,639 mutations, which were not present 
in the dataset that was extracted from UniProt KB. So after merging and sorting the two datasets 
derived from UniProt KB and COSMIC we ended up with 39,196 mutations in 8,277 proteins. 
These 39,196 mutations include 17,093 disease related mutations and 22,103 neutral mutations. Out 
of the complete set of proteins there are 831 proteins containing only disease related mutations, 
5,455 proteins containing only neutral mutations and 1,991 proteins endowed with disease related 
and neutral mutations. For comparison with thermodynamic data we reduce this dataset to the 
mutations corresponding to the 141 types of SNPs available in the ProTherm database. Our reduced 
dataset contains 38,242 mutations, which include 16,476 disease related mutations and 21,766 
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neutral mutations. The reduced and final dataset consists of 8,224 proteins out of which 832 
proteins have only disease related mutations, 5,439 proteins contain only neutral mutations and 
1,953 proteins were endowed with both disease related and neutral mutations. Out of these only 37 
mutations in 29 proteins were found to be residing in active site (ACT_SITE) according to UniProt 
KB annotations.  
 
Table 3.1 SNP mutation data sets 
 
SNP-Data Base SNP (no.) Protein (no.) 
 Disease 
related 
Neutral Total Disease 
(only) 
Neutral 
(only) 
Disease & 
Neutral 
Total 
SNP-UniProt KB 13,456 22,101 35,557 446 6,261 1,185 7,892 
SNP-COSMIC 5,061 2 5,063 2,110 0 1 2,111 
SNP-
UniProt+COSMIC (All) 17,093 22,103 39,196 831 5,455 1,991 8,277 
SNP-Final (with 141 
SNP types) 16,476 21,766 38,242 832 5,439 1,953 8,224 
 
SNP mutations reported for globular proteins, as annotated in UniProtKB and COSMIC data sets, 
are sorted out by disease related, neutral and total mutations, with the corresponding number of 
proteins where the mutations were found. Our SNP-Final dataset is obtained by merging both 
UniProt and COSMIC mutations (SNP-UniProt + COSMIC) and by restricting to the 141 SNP types 
whose thermodynamic data are available in ProTherm. Human non-synonymous single nucleotide 
polymorphisms without annotation involvement in disease are considered non-damaging (Neutral). 
 
 
Figure 3.2 shows a comparison between the residue composition of our dataset (in gray color) to that 
of mutated (yellow bars), disease related (red bars) and neutral (green bars) subsets. The expected 
frequency of mutation for each residue (violet bars) in human genome is nearly the same as the 
overall mutated residues (yellow bars) except in case of ‘Arginine (R)’. Vitkup et al explained the 
high mutation frequency of residue Arginine (R), in the year 2003 as consequences of high mutability 
of 5’ –CpG dinucleotides in the corresponding codons [Vitkup et al, 2003]. The frequency of 
mutation is different for the different residue types and different from the frequency of a given 
residue type in the database set (grey bars). This last value is however very similar to that of the 
human proteome (gray and pale blue bars, respectively) that comprises a much larger number of 
proteins (8,277 and 77,748 protein chains, respectively). Also for most of the residues, the frequency 
of occurrence in the disease related mutation set is similar to that in the neutral set. Exceptions 
include Glycine (G) and Cysteine (C), whose frequency of occurrence is twofold higher in the set of 
disease related mutations than in that of neutral cases and Valine (V) with the reversed occurrence. 
Summing up the 39,196 mutations included in our data set, and annotated in 8,277 proteins represent 
a significant sample of the mutational residue spectrum that can be randomly computed on the basis 
of the actual human Proteome. 
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Figure 3.2 Frequency of residues in the database. Frequency of residues in disease related, 
neutral and total SNP mutation sub-sets of SNP-UniProt+COSMIC  (Table 3.2) and in the 
corresponding total proteins (data base*).  The frequency of residues in the human proteome (from 
EnSEMBL ver 5, based on the build of Genome Reference Consortium 37, with a total of 
34,369,508 residues and 77,748 sequences) and that of the expected mutations rate on the human 
genome are also shown. Residues are grouped as follows: apolar (GAVPLIM), aromatic (FWY), 
polar (STCNQH), charged (DEKR), with residues in the same group listed at increasing order of 
size. 
 
Some of the proteins in our dataset were endowed with as many as above 1000 mutations (table 
3.2). One protein named Cellular tumour antigen (p53), with length 393 residues, is associated with 
a total of 1285 mutations out of which 4 are neutral and 1282 are disease related mutations. About 
69% of cases of our complete dataset restrain 1-3 mutations per protein (Table 3.2).  
 
Disorders, as annotated in the Online Mendelian Inheritance in Man database (OMIM, 
www.ncbi.nlm.nih.gov/omim), were grouped into 22 disorder classes based on the affected 
physiological system, as previously described [Go et al., 2007]. We distinguish genetic cancer from 
somatic cancer ending up with 23 disorder classes, and when necessary neutral mutations are 
grouped in a specific class. 
 
3.1.3 GO Terms 
 
We downloaded GO terms from the current release (April 19, 2010) of the Gene Ontology 
vocabulary (GO) (http://www.geneontology.org/). It was containing 30282 terms, clustered in 
biological process, cellular component and molecular function. In our analysis we consider all the 
GO terms of each protein for each main root. 7270 proteins of our data set are endowed with GO 
terms: 6028 proteins with cellular components, 6455 proteins with molecular functions, and 5829 
proteins with biological processes. 
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Table 3.2 Proteins with the highest number of mutations. 
 
UniprotKB Protein name *L °Tot °D °N 
P04637 Cellular tumor antigen p53  393 1285 1281 4 
P00451 Coagulation factor VIII  2351 456 450 6 
Q8WZ42 Titin  34350 354 131 223 
P60484 Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN  403 319 318 1 
P42771 Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3  156 265 249 16 
P35555 Fibrillin-1  2871 219 202 17 
P10275 Androgen receptor  919 212 209 3 
P12883 Myosin-7  1935 193 184 9 
Q13315 Serine-protein kinase ATM  3056 190 137 53 
P00439 Phenylalanine-4-hydroxylase  452 186 185 1 
P42336 
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit 
alpha isoform  1068 172 169 3 
P06280 Alpha-galactosidase A  429 157 157 0 
P29400 Collagen alpha-5(IV) chain  1685 152 145 7 
P51587 Breast cancer type 2 susceptibility protein  3418 151 91 60 
P00740 Coagulation factor IX  461 143 140 3 
O00255 Menin  615 139 137 2 
P25054 Adenomatous polyposis coli protein  2843 134 122 12 
P40692 DNA mismatch repair protein Mlh1  756 128 110 18 
P35222 Catenin beta-1  781 127 125 2 
P22304 Iduronate 2-sulfatase  550 127 127 0 
P00480 Ornithine carbamoyltransferase, mitochondrial  354 118 112 6 
P02461 Collagen alpha-1(III) chain  1466 116 107 9 
P15056 Serine/threonine-protein kinase B-raf  766 115 114 1 
P34059 N-acetylgalactosamine-6-sulfatase  522 110 103 7 
P21359 Neurofibromin  2839 109 103 6 
P43246 DNA mismatch repair protein Msh2  934 106 93 13 
P30613 Pyruvate kinase isozymes R/L  574 103 102 1 
P15289 Arylsulfatase A  507 100 92 8 
 
28 proteins in our dataset endowed with at least 100 mutations (°Tot), sorted out as disease-related 
(°D), and neutral (°N). *L: protein length in residues. 
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3.1.4 The  3D structure-data set 
 
To train, test, cross validate and compare our predictor of protein stability with other predictors 
employed in the same task we retrieved the 3D structures of mutated proteins from UniProt KB 
released on July, 2009. The set of mutations on proteins with known 3D structure comprises 7347 
mutation examples spread in 1187 protein chains (Table 3.3).  
 
Table 3.3 The 3D-data set of proteins with neutral and disease-related mutations 
 
 Polymorphic 
(only) 
Disease related & 
Polymorphic mutations 
Disease related 
(only) 
No. of mutations 
(Total 7347) 
2338 (32%) - 5009(68%) 
No. of  PDB chains 
(Total 1187) 
803 (67%) 209 (18%) 175 (15%) 
No. of residues 
(Total 328702) 
218578 (67%) 69548 (21%) 40576 (12%) 
 
 
 
The dataset includes 160 types of mutations (mutation couples) and all possible 150 types of SNPs. 
Out of 7347 mutations 2338 (32%) mutations are related to polymorphism and 5009 (68%) belong 
to disease related mutations. Out of 1187 proteins 803 (67%) have exclusively neutral mutations 
and 175 (15%) only disease related mutations, while 209 (18%) are endowed with both disease 
related and neutral mutations.  
 
3.2 Computing expected mutations 
 
The base-line distribution of the residue mutations is computed by considering the frequency of 
occurrence of the four nucleotides namely A (Adenine), T (Thymine), C (Cytosine) and G 
(Guanine) and of the 64 codons in the human genome as reported in the Codon Usage Database 
(http://www.kazusa.or.jp/codon/). For each codon, all the 27 possible single-nucleotide mutations 
are generated. The probability of each mutation is estimated according to a matrix that reports the 
mutation rates of each nucleotide depending on the all 16 possible 5' and 3' neighborhoods [Hess et 
al., 1994]. The distribution of the residue mutations is computed as the sum of the probabilities of 
the corresponding codon mutations.  
 
3.3 Defining different indices  
 
We define two indices in this study namely: the perturbing index and the disease index for each 
SNP mutation of type X Y (where X and Y are wild type and mutant type residues respectively). 
For the computation of these indices we added a pseudo-count of 1 to all the classes under 
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consideration. This smoothing scheme assumes an a-priori equi-probability of the classes correcting 
the probabilities of the mutation types under-represented in the data set [Durbin et al., 1998]. 
 
3.3.1 The Perturbing index (Pp) 
 
We define the perturbation index as the probability of any mutation type X Y to result into 
protein destabilization. For each mutation type X Y we computed the associated perturbation 
probability or perturbation index (Pp) as in equation 3.1. 
 
Pp (XY) = Np (XY)/N (XY)                                              3.1 
 
Where Np (X Y) = Number of X Y mutations with |ΔΔG|>1 kcal/mol 
   N (XY) = total number of mutations XY 
 
3.3.2 The Disease index (Pd) 
  
The disease index may be defined as the probability of any mutation type X Y to be actually 
responsible for causing any disease. For each mutation type XY we computed the disease 
probability or Disease index (Pd) as in equation 3.2. 
 
 
Pd(XY) = Nd (XY)/N(XY)                                             3.2 
 
Where Nd(XY) = total number of X Y mutations conductive to any kind of disease 
 N(X Y) = Total number of X Y mutations 
 
 
3.4 Computing standard errors 
 
For evaluating the Pp(XY) and Pd(XY) Standard Errors (SEPp(XY) and SEPd(XY)) a 
binomial distribution can be reasonably applied (equation 3.4). 
 
SEPx (XY)= ([Px(XY)  (1- Px (XY))/ N(XY)]) ½                   3.4 
 
Where x is either p (perturbing index) or d (disease index).  
 
However samples of data generated considering the diseases class partition have distributions, 
which depart from the traditional parametric distributions. In this case classical hypothesis-testing 
procedures based on strong parametric assumptions cannot be used to estimate the confidence 
intervals. Therefore we adopt also a bootstrap method that makes no assumption about the different 
data distributions. In the case of SEPp(XY) and SEPd(XY) we verify that values obtained with 
Equation 3.4 and the bootstrap procedure are similar. The standard errors reported in this work for 
all the different data sets are obtained with bootstrapping as follows. One thousand re-samples were 
generated starting from the different original data sets (Pp, Pd) by a random extraction with 
replacement. The size of each resample is set to be 90% of the complete dataset and the value of 
each index for each sample is computed. The standard deviation across the 1000 re-samples is then 
the standard error [Moore and McCabe, 2004]. 
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3.5 Computing the regression line and the weighted residuals 
 
For computing a regression line we adopted a Bivariate Least Median Square (BLMS) method 
previously described [Río et al., 2001]. The method is suited to compute the correct regression line 
when outliers are possible in the data set and it is based on a regression procedure that takes into 
account errors on both axes.  The regression coefficients of the regression line are computed by 
minimizing the median of the weighted residuals (Ri) for each data pair (xi, yi) that are defined as 
in equation 3.5. 
 
Ri= (yi-yi*)2/Wi                                                                  3.5 
 
Where  yi = experimental variable 
yi*= prediction of the experimental variable yi   
Wi = the weighting factor that corresponds to the variance of the ith-residual.  
 
 
The method is based on an iterative process performed with the Monte Carlo simulation method to 
obtain the BMLS straight line as the best line of a group of robust straight lines generated by taking 
into account the errors in both axes. 1000 iterations were chosen for the Monte Carlo simulation 
stage. When necessary lines parallel to the regression one are drawn at a y distance equal to the root 
mean square of the residuals (root mean square error, RMSE (equation 3.6)) 
 
RMSE =( (yi– yi*)2/(n - 2) ) ½                                    3.6 
Where n is the number of data pairs. 
 
3.6 Computing correlation and its statistical significance 
 
We checked the normality of the data sets with the Jarque-Brera (1980, 1987) Lagrange Multiplier 
test (LM) and its significance from tables listing values for LM statistics computed with a Monte 
Carlo simulation [Wuertz and Katzgraber, 2009]. For detecting correlation we computed the 
Pearson product-moment correlation coefficient (r) (equation 3.7). 
 
r(x,y)  = cov (x,y) / ((x)  (y))                                                 3.7 
 
Where cov = covariance  
   = Sample standard deviation.  
 
In order to estimate the statistical significance of r, we computed the associated P-value that 
estimates the probability that the value of the correlation coefficient is due to chance (the null 
hypothesis is that data are not correlated). Given r and the number of data (n), we compute the value 
(equation 3.8). A two-tailed test is performed for estimating the P-value. Routinely in our analysis 
P-values >0.05 is considered as the indication of non-significant correlation. 
 
t = [r(x,y)(n-2)1/2]/[1-r (x,y)2] ½                                                                                      3.8 
 
Where t = distributed on a Student’s t distribution with n-2 degrees of freedom.  
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Large error components reduce the apparent correlation coefficient and disattenuation (the 
estimation of the correlation in a manner that accounts for measurement errors contained within the 
estimates of the correlation parameters) is evaluated as follows: 
 
r*(x,y)=r (x,y) [(1- ASE(x)2/(x) 2) (1- ASE(y)2/(y)2)] ½                                               3.9 
 
Where r(x,y), (x), (y) are as in Equation 3.7, ASE is Average Standard Error (for SE definition 
please see Equation 3.4) of the data [Spearman 1904/1987; Francis et al., 1999]. The r* significance 
was evaluated by computing a P*-value as described above. 
 
In order to have correlation coefficients less sensitive to non-normal distributions and non linear 
dependence, correlation was also estimated with the Spearman's rank correlation coefficient (that 
assumes that the variables under consideration were measured on at least an ordinal (rank order) 
scale) and the Kendall tau rank correlation coefficient (that represents the difference between the 
probability that the observed data are in the same order for the two variables versus the probability 
that the observed data are in different orders for the two variables) [Hill and Lewicki, 2007)]. 
Significance tests were performed accordingly and as previously described [Myers and Well, 
2003)].  
 
3.6.1 Spearman's rank correlation coefficient 
 
The Spearman’s rank correlation coefficient or Spearman’s rho is often thought to be Pearson 
correlation coefficient between ranked variables. It assumes that the variables under consideration 
were measured on at least an ordinal (rank order) scale. It calculates the soundness of the 
relationship between two variables using a monotonic function. If there are no repeated data values, 
a perfect Spearman correlation of +1 or −1 occurs when each of the variables is a perfect monotone 
function of the other. It is abbreviated as ‘ρ’. 
 
3.6.2 Kendall tau rank correlation coefficient 
It is a measure of rank correlation that is the similarity of the orderings of the data when ranked by 
each of the quantities. It is commonly known as Kendall's tau (τ) coefficient [Nelsen R.B et al 
(2001)]. It is used to measure the association between two measured quantities. It is used as a 
statistical test in statistical hypothesis test to establish if the two variables are statistically dependent 
on each other or not. Since it is a non-parametric test it does not depends on any assumptions on the 
distribution of variables X and Y (X and Y are independent variables). The Kendall tau τ coefficient 
is defined as in equation 3.10 
 τ =   (Number of concordant pairs) – (Number of discordant pairs)                                    3.10 
           ½ n (n-1) 
The denominator is the total number of pairs, so the coefficient must be in the range −1 ≤ τ ≤ 1. 
 If the agreement between the two rankings is perfect (i.e., the two rankings are the same) the 
coefficient has value 1. 
 If the disagreement between the two rankings is perfect (i.e., one ranking is the reverse of 
the other) the coefficient has value −1. 
 If X and Y are independent, then we would expect the coefficient to be approximately zero. 
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3.7 Statistical evaluation of GO terms by means of a P-value analysis 
 
To assess whether a GO term is significant for a disease class, we performed a statistical test by 
computing P-values as previously described [Bartoli et al, 2009]. If N is the number of sequences in 
a given class which correspond to the same specific GO term, the P-value is the probability of 
finding N or more proteins that have a given annotation by chance, given the dimension of the class, 
the dimension of the data base and the overall number of sequences in the original data base with 
the given annotation. For each GO term within a cluster the corresponding P-value is evaluated as 
in equation 3.11. 
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Where D = total number of protein sequences containing disease related mutations with at least one                 
associated GO term 
 N = number of sequences in each disease class with at least one associated GO term 
 K =number of sequences with disease associated mutations in the entire database which have 
associated the same specific GO term. To account for the multiplicity of the GO terms in each class, 
we applied the Bonferroni correction to the computed P-values [Moore and McCabe, 2006]. 
 
 
 
3.8 Matthews correlation coefficient (MCC) 
 
In the second part of the thesis to assess the performance of different predictors in predicting the 
stability changes caused by single point mutation in proteins different parameters are computed: 
accuracy, Matthews correlation coefficient (MCC), sensitivity and specificity of stabilizing and 
destabilizing mutations. . The Matthews correlation coefficient is defined as in equation 3.12. 
 
MCC= TP*TN – FP*FN / ((TP+FP)(TP+FN)(TN+FP)(TN+FN)) ½      3.12                         
 
Where TP = True Positives 
 TN = True Negatives 
 FP = False Positives 
 FN = False Negatives 
 
For our predictor the true positive is the number of destabilizing mutations predicted as 
destabilizing, false positive is the measure of stabilizing mutations predicted as destabilizing 
mutations, true negative is the measure of stabilizing mutation predicted as stabilizing mutations 
and false negative is the measure of destabilizing mutation predicted as stabilizing mutations. 
 
Sensitivity and Specificity are intended as statistical measures of the performance of a binary 
classification test. Sensitivity measures the proportion of actual positives, which are correctly 
identified, whereas Specificity measures the proportion of negatives, which are correctly identified. 
Theoretical optimal predictions can achieve 100% sensitivity and 100% specificity. The predictors 
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predict the result in binary form as stabilizing or destabilizing mutations. In order to assess the 
performance of different methods Sensitivity [TN/(TN+FP)] and Specificity [TN/(TN+FN)] of 
destabilizing mutations and Sensitivity [TP/(TP+FN)] and Specificity [TP/(TP+FP)] for stabilizing 
mutations are calculated. The overall accuracy of the predictor is then calculated as:   
 
Q= (TN+TP)/(TN+TP+FN+FP)       3.13 
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Chapter 4. Feature encoding for a NEW predictor  
 
A new predictor was implemented to predict whether a single residue mutation perturbs the stability 
of a protein structure. Perturbing mutations are defined as the mutations that affect the Gibbs free 
energy of folding for more than 1Kcal/mol. The predictor is based on SVMs. We tested several 
kernels and we found that the most convenient for the problems at hand is the one based on Radial 
Basis Functions.  
 
RBF kernel = exp [-G|| xi  - xj ||2 ]                                                4.1 
 
The results described are therefore relative to RBF kernels only. Our predictor fetches both local 
and global information from the respective mutated residue, protein sequence and protein structure. 
The global information refers to the properties, which are based on whole protein sequence of the 
respective mutated residue for example length of the protein chain, residue composition of the 
protein chain etc. Local information refers to the properties based on the local environment around 
the mutated residue like physiological properties of the mutated residue, types of residues in contact 
with the mutated residue in a 3-diamentional environment etc.  
 
The predictor carries out the classification task by identifying two labels. If |ΔΔ G| ≤1 kcal/mol then 
the mutation is predicted to be neutral and perturbing otherwise. Based on this threshold the 
predictor gives result as ‘–1’ (if | ΔΔ G| < 1) for perturbing mutations and ‘1’ (|ΔΔ G |≥ 1) for non-
perturbing mutations. The input vector includes different features extracted from the protein 
structure. The features are: 
 
 
4.1 Average contact information 
 
By saying the contact tendency of any residue we mean to say the number and type of particular 
residue, found in contact with the target residue (the mutated wild type residue). The residues j and i 
are said to be in contact if the Euclidean distance between nearest atoms of the residue i and residue 
j is less than or equal to the pre assigned value of the threshold (9 Å in our case). The complete 
spherical 9 Å area around the target residue is known as ‘Contact sphere’. The Euclidean distances 
between the residues were calculated using the equation 4.2. 
 
D= √ ((x1-x2) 2+(y1-y2) 2+(z1-z2) 2)                                                               4.2 
  
Where x1, y1, z1= x, y, z co-ordinates of target residue respectively  
 x2, y2, z2= x, y, z co-ordinates of other residue respectively 
 
This information is encoded by vectors of value 20 (for 20 standard amino acid residues). We 
inserted value ‘100’ in place of the residue for its presence and ‘0’ for rest of the residues. 
 
 
4.2 Profile information and PSSM generation 
 
The Profile Specific Interactive (PSI) BLAST is a very strong and efficient measure of depicting the 
residue conservation in an environment. A matrix consisting of such vector representations for all 
the residues in a given sequence is known as Position Specific Scoring Matrix (PSSM). The 
sequence of the protein with mutation were scanned against the reference datasets to compile a set 
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of alignment profiles and Position Specific Scoring Matrices (PSSM) using PSI BLAST. Three 
cycles of PSI BLAST were run for each of the protein sequence and the scores were saved as profile 
matrices (PSSMs). The inputs consist of the PSSM of the target residue. 20 input vectors represent 
each residue. 
 
4.2.1 Generation of profile files 
 
We built sequence profiles of each protein having mutations in our 3 D structure dataset via a two-
step method. 
 
 We performed BLAST-p for all the chains of our 3D structure dataset against UniProt KB 
database, which included both reviewed, and non-reviewed entries from Swissprot and 
TrEMBL respectively. With this step we searched for the similarity of the sequences in our 
3D structure dataset and complete database of UniProt KB. 
 
 In the second step we separated the sequences with at least 25% identity and calculated the 
frequency of each residue at each position.  
 
The conservation value of each residue at each position for all 20 amino acid residues along with 
gap (so total 21 residues) ranges between 0 and 100, and for each position this conservation value 
sums up to 100 (including gap). 
 
 
 
4.3 Target residue information 
 
For feeding SVM the information regarding the wild type residue and mutant residue we inserted as 
value ‘-1’ for the target residue (wild type residue to be deleted), ‘1’ for the inserted new residue 
(mutant residue) and for rest of the residues the value is kept to be ‘0’. Finally we get a vector of 20 
values (for 20 standard amino acid residues) with values –1, 1 and 0. 
 
4.4 Relative solvent accessibility  
 
We calculated the accessibility of the target (mutated) residues using DSSP (Define Secondary 
Structure of Proteins) program (Figure 4.1). Then we normalized the accessibility values with the 
free residue surface (relative accessibility) of the residue at hand as follows: 
 
Relative accessibility = Accessibility value from DSSP/ Maximal accessibility value   4.3 
 
We set a threshold of 0.16 for distinguishing between core and non-core region. So if the 
normalized accessibility value of the target residue is less than 0.16 we considered it to be present in 
the core region else in non-core region. We computed the frequency of residues of both the classes 
falling in the core (normalized solvent accessibility <= 0.16) and non-core region (normalized 
solvent accessibility > 0.16) of the protein. For a structure-based prediction relative solvent 
accessibility can be used as information for feeding the SVM method, giving rise to the increment 
of one more input vector. The input vector in this case is encoded by a single value representing the 
relative solvent accessibility of the target residue.  
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Figure 4.1 Frequency of mutated residues to lie in the non-core part of the protein (i.e. ASA > 
0.16) and frequency of mutated residues to lie in the core of the protein (ASA <= 0.16). 
 
 
4.5 Protein sequence composition 
 
Protein sequence composition can be considered as one of the most basic input feature. As global 
information, it gives the information about the frequency of different amino acid residues in a 
protein chain. The distinctive features of these 20 amino acids are size, electrical charge, polarity 
and shape. This information can be encoded by using a vector of value 20 (as we have 20 standard 
amino acid residues) each value indicating the contribution of the respective amino acid residue in 
protein sequence.  
 
4.6 Secondary Structures 
 
The interactions if amino acid residues among each other along with the polypeptide chain and with 
the solvent surrounding it determines the stability of 3- dimensional structure. Secondary structures 
like β sheets, α helix and loops etc are the most common secondary structure conformations found 
in polypeptides. These conformations are found to be responsible for the formation of energetically 
favourable structures. However in the protein world the DSSP algorithm is considered to be the 
standard and most popular method for assigning secondary structure to the amino acid residues of a 
protein, given the atomic resolution of co-ordinates of its atoms [Kabsch and Sander (1983)].  DSSP 
recognizes eight types of secondary structures depending upon the pattern of hydrogen bonds. 
DSSP annotation for secondary structure are H (Alpha Helix), B (residues in isolated beta – bridge), 
E (extended strand, participate in beta ladder), G (3-helix (3/10 helix)), I (5 helix (pi helix)), T 
(hydrogen bonded turn), S (bend), L (loop). These eight secondary classes are again regrouped into 
three major classes: 
 
(1) Helix: It includes three classes 3-helix (3/10 helix) (G), Alpha Helix (H) and 5 helix (pi 
helix) (I) 
(2) Strand: It includes two classes extended strand, participate in beta ladder (E), residues in 
isolated beta – bridge (B) 
(3) Loop: Rest other three classes hydrogen bonded turn (T), bend (S) and loop (L) are regarded 
as the part of loop. 
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We calculated the frequency of association of different DSSP annotated secondary structures with 
polymorphic and disease related mutated residues. 3 input vectors encode the secondary structure 
information in SVM as input.  
 
4.7 Implementing a NEW method 
 
We have used Support Vector Machines in this method. The architecture of the method is similar to 
that which is used in I Mutant 2.0. In this new method we have exploited the evolutionary 
information in the form of PSSM matrices on top of all the other information, which improved the 
performance of the predictor. So in conclusion a sum total of 105 input features are fed to this SVM 
machine (Table 4.2). 
 
Table 4.2 Input vectors used in the new predictor 
 
Input Vectors Properties Number of vectors 
Target (Mutated) residue information 20 
Residue composition of protein sequence 20 
Frequency of residues in 9 Å contact sphere 
(in the case of structure based prediction) 
20 
Average Composition of residue in contact sphere 20 
PSSM values 
(Position Specific Scoring Matrix) 
20 
Relative Solvent Accessibility 
(only in the case of structure based prediction) 
01 
Secondary structure information 03 
Conservation of residue 01 
Total vectors 105 
 
 
The NEW predictor fetches different local and global information from protein structure. Figure 4.2 
shows the schematic representation of the working of the NEW predictor. Each of the ovals 
represents either one of the local or global information along with the value of vector in round 
brackets. All these local and global information is processed in RBF kernel and it gives the value of  
|ΔΔ G|. Table 4.3 shows the performance of NEW predictor in different prospects. 
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Figure 4.2 Schematic representation of ‘NEW’ predictor. Local and global properties are 
represented in each of the ovals along with the value of vectors in round brackets. 
 
 
 
Table 4.3 Performance of NEW predictor 
 
 MCC Q Specificity 
Perturbing 
Sensitivity 
Perturbing 
Specificity 
Non-Perturbing 
Sensitivity 
Non-Perturbing 
NEW 0.32 0.68 0.69 0.81 0.64 0.49 
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Chapter 5. Results 
 
5.1 Calculating the Perturbing index (Pp)  
 
We calculated the Perturbing index (Pp) for all the SNPs available in the latest release of ProTherm 
database (released on 31 March, 2010). The dataset contains the data related to 141 SNPs out of 150 
possible SNPs (Figure 5.1). There are few mutation types which are not covered in this work are 
PQ, PH, WG, WC, CF, CW, CR, NY, RI as they were not the part of 
ProTherm data until 31 March 2010. For 98 and 84 types of mutations Pp values can be derived 
from at least 4 and 5 different measurements of the effect of the same mutation on the stability of 
different proteins, respectively. Only 10% of the mutation types are present as a single mutation 
event in the data base and 11% of the Pp values are endowed with a relative standard error > 60% 
(Figure 5.1).  
 
In the Figure 5.1 the darker the colours, the higher is the perturbing index value (Pp). In other words 
the intensity of darkness of each box is relative to the probability of particular SNP to perturb the 
protein stability. Wild type residues are aligned vertically at the left and the target residues lie 
horizontally on the top. Each box shows the corresponding Pp value in bold along with the 
corresponding number of mutations reported in ProTherm and the numbers of proteins associated 
with these mutations are present among round brackets. Pp values with ‘*’ marks shows that the 
calculation is done on less than 4 mutation examples. As explained earlier that this work includes 
141 out of 150 types of SNPs because of their unavailability in the ProTherm database, the boxes 
with ‘**’ sign depicts that the Pp value is not calculated for that particular mutation types because 
the data are not available in ProTherm. Pp values are computed according to equation 3.1.  
 
Residues are grouped as, apolar residues (GAVPLIM, red), aromatic residues (FWY, blue), polar 
residues (STCNQH, green), charged residues (DEKR, yellow), with residues in the same group 
listed at increasing order of their size. The boxes comprising mutations within the same residue 
group are coloured in red, blue, green and yellow, respectively. All the other off diagonal squares 
comprising mutations included in different groups are shown as a combination of the four colours. 
 
The perturbing index values range from smallest value of 0.13 for S N mutation to the maximum 
value of 0.94 for I T mutation. The average Pp value is 0.51 with an average standard error (SE) 
if 0.16. The distribution of Pp values in the dataset shows maximum types of SNP mutation carries 
Pp value of 0.5. The perturbing index value for each mutation type indicates the thermodynamic 
effect of that particular mutation on the stability of protein. The mutation type with a Pp value of 
0.70 indicates that this particular mutation type has 70% probability to perturb the protein stability. 
There are some mutation types like V M, L H, G A, G W, P S, L R, L H, L F, 
D Y, H P, H R, N H, N K, P S, Q P, Q R, R M, T A and W L which have 
Pp value of 0.50. The perturbing index value of 0.50 is considered to be the neutral discriminative 
threshold among non-perturbing and perturbing values. The Pp values of 81 SNP mutation types out 
of total 141 SNP mutation types of our dataset are found to be greater than the Pp value of 0.50, 
symbolizing that 67% of the mutation types in our dataset are perturbing although to different 
extent. The remaining 43% of the mutations types are similarly classified as non-perturbing (with a 
low/modest perturbation probability, according to our definitions of perturbing index). 
 
 
 
 
 
 31
 
 
 
 
Figure 5.1 Values of the Perturbation Probability index (Pp) for each mutation type. The darker 
the colour, the higher the Pp value. Wild type residues are shown on the left, target residues at the 
top. For each mutation type the corresponding number of mutations reported in ProTherm and, 
among round brackets, the number of proteins in which mutations were tested are shown (* marks 
Pp computed from less than 4 mutations). Pp is not computed (**) for a mutation type when data 
are not available in ProTherm. Pp values are computed according to Equation 1. Residues are 
grouped as follows: apolar (GAVPLIM, red), aromatic (FWY, blue), polar (STCNQH, green), 
charged (DEKR, yellow), with residues in the same group listed at increasing order of size. Squares 
comprising mutations within the same residue group are coloured in red, blue, green and yellow, 
respectively. All the other off diagonal squares comprising mutations included in different groups 
are shown as a combination of the four colours. 
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Table 5.1 Correlation of Pd and Pp values with different methods 
 
Index§ Type r r2 Pr r* r*2 Pr* Corrs Ps Corrk Pk 
Pd /Pp 141 0.466 0.217 5.7E-09 0.640 0.409 1.3E-17 0.463 7.2E-09 0.325 2.4E-08 
Pd° / Pp 141 0.489 0.239 7.8E-10 0.669 0.447 1.3E-19 0.495 4.4E-10 0.352 1.5E-09 
Pd^/ Pp 141 0.491 0.241 6.2E-10 0.672 0.452 7.4E-20 0.495 4.3E-10 0.351 1.6E-09 
 
Pd /Pp* 150 0.524 0.274 6.1E-12 0.728 0.530 1.5E-25 0.511 2.3E-11 0.365 8.6E-11 
Pd°/Pp* 150 0.544 0.296 6.2E-13 0.753 0.568 3.6E-28 0.539 1.2E-12 0.387 5.7E-12 
Pd^/Pp* 150 0.547 0.299 4.7E-13 0.757 0.572 1.6E-28 0.538 1.3E-12 0.386 6.2E-12 
 
Pp=perturbation index (Equation 3. 1), Pd=disease index (Equation3. 2); Pd° = without somatic 
cancer mutations in the set (16.5% of the final set). Pd^= without cancer associated mutation in the 
set (18.6% of the final set). In the second set of rows the reference set is All (Table 3.1) and the 
number of mutations without somatic cancer and without cancer. In this case Pd is evaluated for 
the 150 possible mutation type and the missed 9 Pp values (Pp*) are computed from the regression 
line in Figure 5.3. Methods:  r=Pearson correlation coefficient (Equation 3.7); r2= strength of r; 
Pr= significance (P-value) (Equation3. 8); r*, r*2, Pr* as before when standard errors of the data 
are considered (Equation 3.9); Corrs, Ps: Spearman correlation coefficient and the correspondent 
P-value; Corrk, Pk: Kendall correlation coefficient and the correspondent P-value. Type: number of 
SNP mutation types. 
 
In order to confirm that our Pp index is a general estimator of the mutation effect on protein 
stability we correlated its values with a set of different matrices computed under different 
assumptions (Table 5.1). Pp values are correlated with symmetrical and asymmetrical substitution 
matrices. The correlation is also computed for Pp values obtained with a decreasing number of 
mutation pairs, depending on how many experiments were in ProTherm. Correlation values are 
lowering with symmetric than with asymmetric matrices. We obtained a reduced dataset by 
applying a constriction that at least 5 experiments must be available in ProTherm database for 
computing its Pp value for each mutation type. When a reduced number of Pp values is considered 
the correlation increased. In all the cases (Table 5.1) correlation is significant as indicated by the 
corresponding P-values. Considering the effect of standard errors on the correlation (Equation 3.9) 
regularly increases the correspondent value (4th column in Table 5.1).  
 
Historical matrices such as the McLachlan’s and the Grantham’s ones are derived from amino acid 
physico-chemical properties, being the latter based on a mean chemical distance for each amino 
acid pair of three basic properties, such as overall chain composition, polarity and molecular 
volume [McLachlan (1971); Grantham (1974)]. For this reason, and only in this case we observe a 
positive correlation value, in all other cases, correlation is negative indicating that the higher the Pp 
value is the lower the probability of observing the targeted substitution as scored under different 
assumptions. 
 
The importance of the physicochemical properties of the protein was described and exploited time 
to time in development of different prediction tools [Tophem CL et al (1997), Dimitri G. (2000), 
Guerois R (2002)]. In line with previous observations, the conservation of the physico-chemical 
properties is not the only important variable when considering mutation effects on protein stability. 
The relevance of polar solvent exposure and of the protein structure was also described. As shown 
in table 5.1 it was observed that when matrices based on properties directly derived from protein 
structures, such as the extent of amino acid exchangeability, and from the weight of the genetic 
code redundancies were considered [Johnson and Overington, 1993; Müller et al, 2002; Crooks and 
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Brenner, 2005], the correlation of the Pp index with the corresponding matrices increases with 
respect to that based on physico-chemical properties and chemical distances.  Furthermore a good 
correlation is also observed when the weight of evolution is taken into account (BLOSUM 62).  
 
Interestingly enough and again in line with what previously discussed, mutations may also be 
asymmetrical in relation to their effect on protein stability. Pp correlation values increase when 
asymmetric substitution matrices are considered [Overington et al., 1992; Koshi and Golstein 1995; 
Yampolski and Stoltfus, 2005] and the best correlation is obtained with the environment-specific 
substitution matrix for accessible residues was taken into account [Overington et al., 1992]. Indeed 
some 32 mutations types (23% of the total) corresponding to 16 mutation pairs have a Pp difference 
(|P(XY) – P(YX)|) >0.3, which is sufficient to include one of the two mutation types below or 
above the 0.5 perturbing threshold value (Figure 5.1). As explained earlier the residue mutation is 
considered to affect the protein stability mainly because of its effect on polarity and steric effect of 
the substituted residue. Considering Pp values and mutation types in Figure 5.1, we noticed that on 
average changing steric effect when a given side chain is mutated from small to large perturbs the 
protein stability more than changing its polarity.  
 
5.2 Calculating the disease index (Pd) 
For each mutation type of any residue type ‘X’ to residue type ‘Y’ (X Y) we computed associated 
probability of this mutation to actually cause a disease, and we called it as disease index (equation 
3.2). SNPs without any annotation of a disease were considered to be non-damaging in our database 
(SNP-UniProtKB+COSMIC, Table 3.1). The disease index values for each mutation type are listed 
in Figure 5.2 with the corresponding number of mutations and number of proteins (in round 
brackets).  
 
All the 150 possible SNP mutations types are present in the set. Wild type residues are aligned 
vertically on the left and mutant residues horizontally at the top. *. Residues are grouped as in Figure 
5.1 apolar (GAVPLIM, red), aromatic (FWY, blue), polar (STCNQH, green), charged (DEKR, 
yellow). The residues falling in the same group are listed in the increasing order of their size. The 
index value ranges from the lowest value of 0.13 for IV SNP up to the highest value of 0.79 for 
CF and WC SNP. The average Pd value is 0.47 with an average standard error of 0.04. Stars 
label the 9 Pd indexes without Pp counterparts that indicate a high/medium probability of disease 
association with the exception of PQ. A Pd value of 0.5 can be considered a natural threshold to 
classify mutation types as endowed with low/medium and high probability of being disease 
associated.  
 
There are 57% of the SNP types, which have Pd values less than 0.5. High Pd values (<0.5) are 
characteristics of mutation type where either the polarity is not conserved or the steric effect 
decreases upon residue substitution. The same characteristics were noted while analyzing the 
spectrum of Pp values. We computed the Pd correlation with the substitution matrices (Table 5.1, 
Pd values). Correlation values are routinely higher than those obtained with Pp. The values are 
higher even when the average standard errors for Pp and Pd were considered Correlation of Pd 
values with substitution matrices is high both for symmetric and asymmetric substitution scoring 
values. The highest correlation value is obtained with the Blosum62 substitution matrix, indicating 
that the more a mutation type is allowed through evolution the less it is conducive to disease. 
Summing up, for the Pd index different physico-chemical and protein structural features are 
conducive to Pd values as indicated by the significant correlation observed with scoring matrices 
derived under different assumptions (Table 5.1, Pd values).  
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Figure 5.2 The disease index values (Pd) for each mutation type. The darker the colour, the higher the 
Pd value. Wild type residues are shown on the left and target residues at the top. For each mutation type 
the corresponding number of mutations and, between round brackets, the number of proteins in which 
mutations are annotated, are shown. Pd is computed for the 150 possible SNPs; when for a given SNP 
type no thermodynamic data are available in Protherm, the corresponding Pd is marked with *. Residues 
are grouped as in Figure 5.1 apolar (GAVPLIM, red), aromatic (FWY, blue), polar (STCNQH, green), 
charged (DEKR, yellow), with residues in the same group listed at increasing order of size. 
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5.3 Correlating Pp and Pd  
 
The properties of the mutational spectrum are encoded into a pair of indices for each mutation type. 
The mutational spectrum can also be shown for 141 SNP types out of the 150 possible SNP 
mutations due to the lack of thermodynamic data for the rest of the 9 mutation types.  We are now 
in the position of testing whether the two indexes (Pp and Pd) correlate. We find a linear correlation 
between Pp and Pd values for each mutation type (141 mutation types) (Figure 5.3), where all the 
data are plotted with the corresponding standard error as evaluated with bootstrapping method. The 
regression line is computed along with parallel lines drawn at a y distance equal to one and two 
fold/s the root mean square of the residuals.   
 
 
 
Figure 5.3 Correlation between Pd and Pp Correlation among the disease (Pd) and the perturbing (Pp) indexes for 
141 SNP mutation types. The regression line is computed with BLMS regression,(Materials and Methods). Pearson 
correlation  (Corr) and P-value are computed with equation 3.9 and 3.8, respectively. Lines parallel to the fitting one 
are drawn at y distance equal to one/two fold the root mean square of the residuals (root mean square error (Equation 
3.6), RMSE=0.181). 
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Our results indicate that Pd and Pp significantly (with low P-values) correlate with different 
combinations as shown in Table 5.1. The strength of the correlation (r2) is about 20% and it doubles 
when the standard errors of the data are considered. This value indicates that the correlation is 
moderate/good. The correlation increases when a large fraction of the data (about 18%, cancer 
related mutations) is removed from the data set (Figure 5.4).  
 
 
 
 
Figure 5.4 Correlation between Pd and Pd° values. Pd values are computed for the 150 SNP types considering all the 
mutation data set (SNP-UniProtKB+COSMIC, Table 3.1); Pd°: mutations annotated as somatic cancer-related are 
removed (16.5% of the total mutations in SNP-UniProtKB+COSMIC; remaining mutations: 32,714) and Pd° is 
computed. The regression line is computed with a BMLS method (Materials and Methods). Lines parallel to the fitting 
one are drawn at a y distance equal to one and two fold the root mean square value of the residuals (root mean square 
error (Equation 3.6), RMSE=0.056).  
 
 
 
 
RM
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Pd
Pd
°
RI 
KM 
EQ
IV 
y = 1.177x - 0.197 
Corr = 0.951 
P-value = 1.4E-77 
 37
In Figure 5.5 A and B residuals (the differences between Pp(XY) and the corresponding fitting 
value on the fitting line BLMS(XY)), weighted with respect to the variances of the mutation type 
XY on both axes are plotted as a function of Pd and Pd° (values computed without somatic 
cancer mutations). Noticeably most of the mutation types have a weighted residual that clusters 
within one standard deviation from the average of the distribution value for both sets of values. In 
both cases two outliers are detected: VA and IT. We can conclude that for these mutation types 
the Pp value is much higher than that expected considering the Pd associated value.  The 
correspondent Pd indexes (0.26 and 0.38 for VA and IT, respectively) indicate a moderate 
tendency to be disease related.   
 
 
 
Figure 5.5 Weighted residual analysis of the Pd/Pp regression Differences between Pp(XY) and the 
corresponding fitting value on the fitting line BLMS(XY), weighted with respect to the variance of the mutation type 
XY on both axes (Weighted residual) with respect to Pd values (Pd). (A) all the  (SNP-UniProt+COSMIC) data 
base.(B) The analysis is restricted to diseases of genetic origin, with the exclusion of SNPs annotated as somatic 
cancer (Pd*). The mean value of the residuals (Avg) and the corresponding standard deviation () are shown for 
reference. The mutation type (XY) is only shown for residual values >1. 
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5.4 The NEW Predictor at work  
 
The second part of this work consists of development of a predictor, to classify destabilizing and 
stabilizing mutations with respect to protein structure and its testing with our 1st result. We 
developed a SNP predictor (discussed in chapter 4). Our predictor is competent to discriminate 
between perturbing and non-perturbing mutation with an overall accuracy of 68%, which is highest 
among all the predictors involved in this study when tested starting from the protein structures. 
When predicting ΔΔG values associated with mutations, the Matthews correlation coefficient value 
is 0.32, which is best among all the other predictors (Table 5.2). 
 
Table 5.2 Comparison between the performances of different predictors. 
 
Threshold |ΔΔG|= 
1.0 kcal/mol 
MCC Q Specificity_ 
perturbing 
Sensitivity 
perturbing 
Specificity 
non-
perturbing 
Sensitivity 
non-
perturbing 
I Mutant 2.0 0.17 0.57 0.55 0.76 0.63 0.39 
I Mutant 3.0 0.17 0.54 0.46 0.78 0.73 0.38 
Fold-X 0.24 0.58 0.51 0.81 0.75 0.41 
Popmusic 2.0 0.28 0.66 0.69 0.79 0.61 0.48 
NEW 0.32 0.68 0.69 0.81 0.64 0.49 
 
* For scoring index definition see above. 
 
Strengths of NEW predictor: 
 
(1) It can be concluded from Table 5.2 that our NEW predictor is best among all other state of 
the art predictors, whether they are energy function based predictors like PoPMuSiC and 
Fold-X or Machine Learning based predictors like I Mutant 2.0 and I Mutant 3.0. 
 
(2)  Secondly in our later sections it has been proved that the predictions of our NEW predictor 
is in line with the probability indices calculated as the first part of the work. 
 
5.4.1 Computing Pp and Pd for the 3D Structure dataset 
 
We calculate the perturbing index values (equation 3.1) and disease index values (equation 3.2) 
over the 3D structure dataset used to train/test the NEW predictor. This corroborates the view that 
the predictive method is capable of correctly annotating the mutation as neutral and disease related. 
Indeed the results obtained by computing the probability indexes and their correlation prove that 
protein perturbation in the data bases correlates with probability of being disease-related of a given 
mutation. With the NEW predictor we can now compute the extent of perturbation of a given 
mutation starting from the protein structure. Also the mutation is or is not disease related. By 
correlating perturbing index from the predicted data and the probability disease index over the 3D 
structure data set we are now in the position of validating our predictor performances.  
 
Table 5.3 The 3-D structure-SNP dataset 
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 Polymorphic Common in 
polymorphic and 
disease related 
mutations 
Disease related 
Mutations 
No. of mutations  
(Total =7300) 
2318 
(32%) 
- 4982 
(68%) 
No. of  PDB chains (Total= 
1185) 
803 
(68%) 
207 
(17%) 
175 
(15%) 
No. of residues according to 
PDB 
(Total=327035) 
218578 
(67%) 
67881 
(21%) 
40576 
(12%) 
 
The 3-D structure-SNP dataset was created after excluding all the non-SNP data from the 3-D 
Structure dataset used for the predictor (table 3.3) 
 
The 3D Structure-SNP dataset contains only those SNP related mutation examples for which the 3-
D structures are known and comprises 7300 mutations in 1185 proteins. 2318 (32%) of the total 
SNP mutations were polymorphic and rest 68% (4982) SNP mutations were disease related. 68% of 
the protein structures were having only polymorphic mutations and 15% of protein structures were 
having only disease related mutations, whereas 17% protein structures were endowed with both 
disease related as well as polymorphic mutations (Table 5.3).  
 
 
5.4.2 Correlation between calculated perturbing index (Pp) and predicted 
perturbing index (Pp-3D)  
 
 
We calculated perturbing index values (Pp) (equation 3.1) for our 3 D structure–SNP dataset, based 
on the predicted ΔΔG values by our NEW predictor (Pp-3D). The Pp-3D values are well correlating 
(Figure 5.6) with the previously calculated Pp values for the whole mutation data set (ProTherm 
database (released on 31 March, 2010), Table 3.1) (in Figure 5.1). The regression line is calculated 
using the BMLS method The two perturbing values are significantly correlating with a Pearson 
correlation coefficient of 0.49 and a low P-value of   6E-10 which indicates the significance of this 
correlation.  
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Figure 5.6 Correlation between calculated perturbing index value (Pp) (equation 3.1) and 
perturbing index values calculated with predicted ΔΔG by new predictor (Pp-3D). The regression 
line is computed with a BMLS method (Materials and Methods). Pearson correlation coefficient = 
0.49, P-value= 6E-10 
 
 
 
5.4.3 Correlation between disease index (Pd) values for the whole mutation dataset 
and disease index values for the 3D Structure-SNP dataset (Pd-3D) 
 
 
The disease index values for the 3D structure dataset (Pd-3D) are well correlating with the disease 
index values calculated for the whole mutation dataset (SNP-UniProtKB+COSMIC, table 3.1) 
(Figure 5.7). The disease index values for two datasets are correlating with Pearson correlation 
coefficient of 0.75 and a P-value of 9E-28. The regression line is computed with a BMLS method 
(see Materials and Methods). Interestingly enough it turns out that the reduced set including 
proteins endowed with a 3D structures collects a relative abundance of disease related SNPs higher 
than that in the whole data base of mutations. This is noticeable from the intercept of the regression 
line in Figure 5.7 (different from zero). 
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Figure 5.7 Correlation among Pd and Pd-3D values Pd values are computed for the 150 SNP 
types considering all the mutation data set (SNP-UniProtKB+COSMIC (table 3.1)); Pd-3D values 
computed for our 3D-structure dataset (used for our predictor) mutations annotated as somatic 
cancer-related.  The regression line is computed with a BMLS method. Pearson correlation 
coefficient= 0.75, P-value = 9E-28.  
 
 
5.4.4 Correlation between Pp-3D and Pd-3D 
 
Finally the two indices (Pp-3D and Pd-3D) are well correlated (low P-value (4E-08)) with a Pearson 
correlation coefficient of 0.44. This finding supports the notion that indeed a correlation exists 
among Pd and Pp that is independent from the set of the data set (Figure 5.8) and more importantly 
that our NEW predictor gives predictions that are on line with what present in the mutation data set. 
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Figure 5.8 Correlation between Pp-3D and Pd-3D values Pp-3D values are computed for the 141 
SNP types considering only 3D-Structure-SNP dataset (table 5.3); Pd-3D values are disease index 
computed for the same dataset. Pearson correlation coefficient= 0.44, P-value= 4E-08, RMSE = 
0.29. 
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Chapter 6. Conclusions 
 
SNP annotation is an issue in many deep sequencing experiments aiming at clinical association 
studies. In this work and for the first time we tested the hypothesis that mutations conducive to 
disease are also perturbing to some extent the stability of the corresponding protein. In this work we 
have elaborately proved the direct correlation of mutations related to disease and destabilization of 
the related protein. The problem is addressed separately in the pertinent literature. A number of 
predictors are available to predict if a particular mutation is conducive to a disease [Tatvigian et al., 
(2008)] or a particular mutation is perturbing the protein stability [Thusberg and Vihinen, (2010)]. 
Our present effort aims at casting information of the effect of mutation types into features derived 
from the available databases of thermodynamic data (from ProTherm) and SNP description data 
(from UniProtKB) at the protein level. For each mutation type we computed two probability 
indices, perturbing index (Pp) and disease index (Pd) that represent the probability of promoting 
perturbation of the protein stability and disease, respectively.  
 
At the very first step of our analysis we compute Pp and Pd maps for the data derived from the 
Universal Protein Resource (UniProt KB) and ProTherm. By this each mutation type is endowed 
with Pd and Pp indexes. The probability indices are computed over a large number of mutations for 
all the mutation types both in relation to mutational data and also to thermodynamic data, when 
possible. The standard error associated to each Pd and Pp values estimates the variability due to 
sampling fluctuation. Given the different volume of available data, Pp has variability (Average 
Standard Error) fourfold larger than Pd (0.16 vs. 0.04).  
 
In the second step of our analysis we proved that the two indices are linearly correlated with only 
two outliers namely V A and I T.  This is obtained with a robust procedure that takes standard 
errors on both indices into account [Del Rio et al., (2001)]. This ensures that the hypothesis of the 
direct relation between a disease causing mutation with the protein stability perturbation cannot be 
rejected (with a strength of about 25%) and that it is likely to be one of the possible molecular 
mechanisms in the whole diseasome [Goh et al., 2007]. Further the correlation computation 
considering only germ line mutations (Pd°) is still significant, with the same outliers (V A and 
I T). This proves that data are not biased by somatic cancer mutations, including some 18% of the 
total mutation data set. 
 
When disattenuation is evaluated [Spearman 1904/1987] and errors are taken into account, results 
indicate that data are compatible with an increased correlation coefficient value (from 0.466 to 
0.640 (please refer table 5.1). Also it is important to point out here that, our error estimator 
indicates, probabilistic indices and their correlation are enough tolerant to increment in database 
volumes that is most likely to occur in the near future giving the great shift of interest in SNP 
detection. 
 
Two outliers V A and I T were also detected. For these mutation types the Pp values are 0.73 
and 0.94 for V A and I T respectively are much higher than that expected considering the 
associated Pd values 0.26 and 0.38 for VA and IT respectively. These values indicate a 
moderate tendency of these mutation types to be disease related.  In ProTherm, mutational data (122 
VA mutations in 37 proteins, and 16 IT mutations in 11 proteins, respectively) are derived 
from proteins whose structure is known with atomic resolution. In both cases about 90% of the 
mutations are located in the protein core region (buried) and rather perturbing as indicated by the Pp 
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values. This sampling is different from average in our data where only 40% of the mutations are 
buried and it can bias this association with low Pd values.  
 
With this statistical analysis we can conclude that all together our results support the notion that the 
perturbing Pp index, as derived from thermodynamic data of mutation effects on proteins, is 
indicative of the effect that a mutation type can have on protein stability. The Pp value sums up 
physico-chemical properties such as solvent exposure, structure conservation and also conservation 
through evolution. Finally the Pp mutation index is enough general and representative of the effect 
of a mutation type on protein stability in spite of the few thermodynamic data presently available in 
the ProTherm database as compared to the amount of data describing the effect of mutations on 
human health and generated as a result of high throughput sequencing methods.  
 
All these observations are crucial in suggesting which types of features are relevant for predicting 
whether a mutation in a protein is or is not disease related. Our NEW predictor, based on support 
vector machines, outperforms existing methods by considering 105 input features. It computes 
whether a mutation is or is not destabilizing the protein structure with an overall accuracy of 68% 
and Matthew correlation coefficient of 0.33. From the predicted values we are also able to derive a 
perturbing index that we call the predicted perturbing index. The “predicted” perturbing index well 
correlates with the one computed over the entire set of thermodynamic data and with the disease 
related index computed over the set of 3D structures presently available. This result support 
therefore the idea that predictors capture much information available in the data sets and can be 
adopted as reliable methods in annotating disease-related mutations. 
 
With the advent of next generation sequencing machines our computational methods will be 
necessary to complement experimental results with efficient and robust systems to endow data with 
labels useful to perform diagnosis and further translate to the clinics. Therefore our effort 
contributes to this line of research and provides support to the notion that machine learning based 
approaches can help in generating valuable tools for biomedical data analysis. Also in the field of 
protein engineering our NEW predictor can help in designing new proteins with higher stability a 
resting to temperature changes. This is particularly useful in the field of bioreactor production for 
generating cell factories competing for the productions of molecules of interest such as drugs, in the 
field of biosensors, and nanotechnology for the development of new materials. 
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